EU MDR Annex XVI Extended to Endoscope Accessories

On 10 May 2026, the European Commission formally adopted Regulation (EU) 2026/XXXX, extending Annex XVI of the EU Medical Device Regulation (MDR) to standalone light sources, video processing units, and camera control systems used with rigid and flexible endoscopy systems. This update directly affects manufacturers and distributors of endoscopic accessories—particularly those supplying into the EU market—and signals a significant shift in regulatory compliance requirements for non-invasive imaging support devices.

Event Overview

On 10 May 2026, the European Commission published Regulation (EU) 2026/XXXX, amending the MDR to expand the scope of Annex XVI to include all independent light sources, camera hosts, and image processing modules intended for use with rigid or flexible endoscopy systems. The regulation enters into force on 1 June 2026. As of that date, affected products placed on the EU market must bear a valid CE marking issued under the updated MDR framework. Products without compliant CE certification will be prohibited from customs clearance into the EU.

Industries Affected by the Change

Manufacturers of Endoscopic Accessories

These companies produce standalone light sources, camera control units, and image processing hardware—not integrated into endoscopes themselves, but essential for their clinical operation. Under the revised Annex XVI, such devices are now classified as Class IIa medical devices, requiring formal conformity assessment by an EU Notified Body. This triggers new technical documentation, clinical evaluation, and quality management system obligations.

Export-Oriented Trading Companies

Firms acting as EU importers or authorized representatives for non-EU manufacturers—especially those based in China—are now responsible for verifying CE compliance prior to shipment. Over 80% of Chinese manufacturers of such accessories have not yet completed the transition to MDR-compliant certification, increasing the risk of shipment delays, customs rejections, or post-market enforcement actions.

Supply Chain & Logistics Providers

Freight forwarders, customs brokers, and warehousing operators handling endoscopic accessory shipments into the EU must now verify CE certificate validity and alignment with Regulation (EU) 2026/XXXX. Documentation checks—including evidence of Notified Body involvement and Annex XVI classification—will become standard pre-clearance requirements starting 1 June 2026.

Key Actions for Relevant Enterprises and Practitioners

Monitor official EU publications for certificate validation criteria

The European Commission and national competent authorities have not yet published detailed guidance on how customs officials will verify Annex XVI compliance for light sources and camera hosts. Enterprises should track updates from the European Database on Medical Devices (EUDAMED) and national market surveillance portals for operational interpretation notes.

Confirm product classification and Notified Body engagement status

Manufacturers and importers must verify whether their specific models fall within the newly defined scope—i.e., whether they are ‘standalone’ and ‘intended for use with’ endoscopy systems. If so, engagement with an MDR-designated Notified Body is mandatory; reliance on legacy MDD certificates is no longer acceptable.

Review and update labeling, declarations of conformity, and technical files

CE marking must now reflect the correct risk class (IIa), applicable harmonized standards (e.g., EN IEC 62304, EN ISO 13485), and Annex XVI designation. Declarations of Conformity must explicitly reference Regulation (EU) 2026/XXXX and include identification of the involved Notified Body.

Assess supply chain timelines for certification readiness

Given that over 80% of Chinese manufacturers remain uncertified, procurement teams should confirm lead times for Notified Body assessments and request interim compliance roadmaps from suppliers. Delayed certification may impact Q3 2026 delivery schedules for EU-bound orders.

Editorial Perspective / Industry Observation

Observably, this amendment reflects a broader regulatory trend: the EU is progressively closing definitional gaps that previously allowed certain ancillary medical imaging equipment to operate outside formal MDR oversight. Analysis shows the extension targets functional interdependence—devices that, while physically separate, are clinically indispensable to endoscopic diagnosis and intervention. This is less a sudden policy shift and more a systematic implementation of MDR’s original intent. From an industry perspective, it signals that ‘accessory’ status no longer confers regulatory exemption—especially where safety and performance rely on tight integration with a Class IIb or Class III device. Continued attention is warranted as enforcement consistency across Member States remains unconfirmed.

In summary, Regulation (EU) 2026/XXXX marks a binding compliance milestone—not merely a procedural update—for manufacturers and distributors of endoscopic light and imaging hardware. Its practical effect is the mandatory reclassification and recertification of previously unregulated standalone components. It is best understood not as an isolated regulatory event, but as a definitive step in the full operationalization of MDR’s scope definition—requiring proactive, documentation-driven preparation rather than reactive compliance.

Source: European Commission Regulation (EU) 2026/XXXX, published 10 May 2026. Note: Implementation details—including Notified Body validation protocols and customs verification procedures—remain subject to ongoing clarification by EU national authorities and are recommended for continuous monitoring.